RIPE-KG · Version 1.1.0 · Resource

ripekg:work/10.3109%2F09637486.2016.1161011

https://w3id.org/ripe/ripe-kg/work/10.3109%2F09637486.2016.1161011
SubjectPredicateObject
ripekg:work/10.1002%2Fptr.6406Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo‐controlled, double‐blind clinical trial http://purl.org/spar/cito/cites ripekg:work/10.3109%2F09637486.2016.1161011Flaxseed supplementation in non-alcoholic fatty liver disease: A pilot randomized, open labeled, controlled study
ripekg:work/10.3109%2F09637486.2016.1161011Flaxseed supplementation in non-alcoholic fatty liver disease: A pilot randomized, open labeled, controlled study prism:doi 10.3109/09637486.2016.1161011
ripekg:work/10.3109%2F09637486.2016.1161011Flaxseed supplementation in non-alcoholic fatty liver disease: A pilot randomized, open labeled, controlled study dcterms:title Flaxseed supplementation in non-alcoholic fatty liver disease: A pilot randomized, open labeled, controlled study
ripekg:work/10.3109%2F09637486.2016.1161011Flaxseed supplementation in non-alcoholic fatty liver disease: A pilot randomized, open labeled, controlled study rdf:type node1
ripekg:work/10.3109%2F09637486.2016.1161011Flaxseed supplementation in non-alcoholic fatty liver disease: A pilot randomized, open labeled, controlled study rdf:type http://purl.org/spar/fabio/Work
ripekg:work/10.3109%2F09637486.2016.1161011Flaxseed supplementation in non-alcoholic fatty liver disease: A pilot randomized, open labeled, controlled study rdf:type rdfs:Resource
ripekg:work/10.3109%2F09637486.2016.1161011Flaxseed supplementation in non-alcoholic fatty liver disease: A pilot randomized, open labeled, controlled study rdf:type owl:Thing
ripekg:work/10.3109%2F09637486.2016.1161011Flaxseed supplementation in non-alcoholic fatty liver disease: A pilot randomized, open labeled, controlled study rdf:type prov:Entity
ripekg:work/10.3109%2F09637486.2016.1161011Flaxseed supplementation in non-alcoholic fatty liver disease: A pilot randomized, open labeled, controlled study rdf:type ripe:WorkWork
ripekg:work/10.3109%2F09637486.2016.1161011Flaxseed supplementation in non-alcoholic fatty liver disease: A pilot randomized, open labeled, controlled study owl:sameAs https://semopenalex.org/work/W2298528870